Consultation over BZP Consumer Screening Process for Retailers

Over 26 million BZP based social tonics have been consumed in New Zealand alone over the last 7 years with relatively few adverse events. However, concerns have been voiced about their widespread availability. Consultation is invited with consumers and other stakeholders on addressing these concerns.

Industry body STANZ advocates regulations to restrict sales of the pills to retail outlets where entry is restricted to persons 18 years of age and over, and to prohibit signage or advertising in places visible to children. Compliance with these regulations is underway.

It is clear that improvements could be made in education at a retail level. It is proposed that the next step at the retail level is in screening customers firstly for age identification, and secondly for contraindications; “Are you on any medicines? Do you have any medical conditions?” etc.

It is further proposed that standardised information brochures on BZP based social tonics are made available at the retail level.

The materials below have been developed for the purpose of consultation with industry, consumers and key stakeholders around a consumer screening process at the point of retail, and an informative brochure which can be standardised for consumers.

We are looking for your feedback. Please download both the retail screen and the brochure from below and write to us with comments at SCREENING FEEDBACK, P O Box 300 840, Albany, North Shore City 0752, New Zealand or matt at stanz.org.nz (replace “at” with @ sign)

Please click here to download retail screen

Please click here to download brochure


Stargate International
Guidelines for safer recreational use.

Please click here to download brochure.

 

 



Stargate International
Tel NZ 0800 STARGATE • Int +64(0)9 478 9477 • Fax +64(0)9 478 9472
www.angelcare.org.nzwww.stanz.org.nz www.designerpills.com